Synonym
CGP 28392; CGP28392; CGP-28392
IUPAC/Chemical Name
Furo(3,4-b)pyridine-3-carboxylic acid, 1,4,5,7-tetrahydro-4-(2-(difluoromethoxy)phenyl)-2-methyl-5-oxo-, ethyl ester
InChi Key
CBPBJKQTVKFOOQ-UHFFFAOYSA-N
InChi Code
InChI=1S/C18H17F2NO5/c1-3-24-16(22)13-9(2)21-11-8-25-17(23)15(11)14(13)10-6-4-5-7-12(10)26-18(19)20/h4-7,14,18,21H,3,8H2,1-2H3
SMILES Code
O=C(C1=C(C)NC(COC2=O)=C2C1C3=CC=CC=C3OC(F)F)OCC
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>3 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.03.00
Preparing Stock Solutions
The following data is based on the
product
molecular weight
365.33
Batch specific molecular weights may vary
from batch to batch
due to the degree of hydration, which will
affect the solvent
volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass |
1 mg |
5 mg |
10 mg |
| 1 mM |
1.15 mL |
5.76 mL |
11.51 mL |
| 5 mM |
0.23 mL |
1.15 mL |
2.3 mL |
| 10 mM |
0.12 mL |
0.58 mL |
1.15 mL |
| 50 mM |
0.02 mL |
0.12 mL |
0.23 mL |
1: Rosenberg FJ, Ackerman JH, Nickel AR. Iosulamide: a new intravenous cholangiocholecystographic medium. Invest Radiol. 1980 Nov-Dec;15(6 Suppl):S142-7. PubMed PMID: 6782035.
2: Park GB, Biddlecome CE, Rowe EA, Kullberg MP, Edelson J. Analysis of iosulamide in plasma and urine: application to intravenous pharmacokinetics in rhesus monkey. Drug Metab Dispos. 1981 Jan-Feb;9(1):43-7. PubMed PMID: 6111430.
3: Marincek B, Young SW, Enzmann DR. Time-density evaluation of the liver after iosulamide meglumine: a tissue-specific CT contrast agent. Invest Radiol. 1982 Jan-Feb;17(1):90-4. PubMed PMID: 7076441.
4: Burgener FA, Ciaravino V, Fischer HW. Failure of iosulamide to enhance hepatic tumors in rats. Invest Radiol. 1982 Jan-Feb;17(1):46-9. PubMed PMID: 7076433.
5: Nelson JA, White GL Jr, Nakashima EN. Iosulamide: human tolerance study of a new intravenous cholangiographic drug. Invest Radiol. 1980 Nov-Dec;15(6):511-6. PubMed PMID: 7203907.
6: Berk RN, Barnhart JL, Nazareno G, Witt BL. The potential of iosulamide meglumine as a contrast material for intravenous cholangiography: an experimental study in dogs. Invest Radiol. 1981 May-Jun;16(3):240-4. PubMed PMID: 7263160.
7: Stude RA, Hedlund LW, Johnson GA, Thompson WM. Contrast enhancement of the liver. Evaluation by automated contiguous pixel search. Invest Radiol. 1987 Feb;22(2):132-6. PubMed PMID: 3030962.
8: Thompson WM, Stude RA, McDonald MI, Halvorsen RA, Dunnick NR, Silverman PM, Korobkin M, Durack DT, Shelbourne J. Computed tomographic evaluation of an experimental model for pyogenic liver abscesses. Invest Radiol. 1985 Mar-Apr;20(2):152-8. PubMed PMID: 3886589.
9: Evill CA, Wilson BC, Benness GT. Quantitative evaluation of biliary x-ray contrast agents in computed tomography. Australas Radiol. 1983 Nov;27(3):258-62. PubMed PMID: 6675660.
